The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector

Written By

deirdre kilroy Module
Deirdre Kilroy

Partner
Ireland

I am an experienced Irish lawyer. I specialise in complex technology, data and IP transactions, and advise innovative clients on the laws and regulations applicable to related products and services offered in Ireland and other parts of the European Union.

georgina parkinson Module
Georgina Parkinson

Associate
Ireland

I am an associate in Bird & Bird's International Commercial Group, based in the Dublin office where I specialise in Technology, Media, Entertainment and Sports.

The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased focus on the risks for medical device manufacturers and healthcare providers inherent in the data they collect and hold, including the risks posed by the ongoing threat of cyber-attacks. This is where the NIS2 Directive and the CER Directive come in.

In this article we will consider the Network and Information Systems Directive (EU) 2022/0383 (“NIS2”) and the Directive on the Resilience of Critical Entities (EU) 2022/2557 (“CER Directive”) and the impact that they will have on medical device manufacturers and healthcare providers.

Read the full article here

Latest insights

More Insights
mountain scape

European Union Artificial Intelligence Act Guide

Nov 06 2024

Read More
Curiosity line yellow background

Transforming A Brand into A Global Business – what to consider from a legal perspective

Nov 05 2024

Read More
Keyboard and tablet on yellow background

New consumer rights in the Polish Electronic Communications Law

3 min Nov 05 2024

Read More